Lexaria Bioscience EPS Diluted from Extraordinaries (Quarterly) Insights

Lexaria Bioscience Corp. (LEXX)

0.6514 -0.01 (-1.27%) USD | NASDAQ | Feb 20, 16:00

0.6434 -0.01 (-1.23%) After-Hours: 20:00

View EPS Diluted from Extraordinaries (Quarterly) for LEXX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	--
Aurinia Pharmaceuticals, Inc.	--
Edesa Biotech, Inc.	--
Xenon Pharmaceuticals, Inc.	--
ProMIS Neurosciences, Inc.	--